Search for: "Cephalon Inc." Results 161 - 173 of 173
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
15 Jan 2008, 6:35 pm
The Cephalon Speaker Series for Science and the Constitution is a partnership between Cephalon, Inc. and the National Constitution Center intended to attract local and national experts to discuss constitutional issues pertaining to science, public policy and the law. [read post]
10 Oct 2007, 9:15 pm
  Manufactured by Cephalon, Inc., Fentora is most commonly prescribed to treat breakthrough pain in terminal cancer patients who have already developed a tolerance to opioid pain medications. [read post]
20 Sep 2007, 3:04 pm
This medication, made by the drug company Cephalon, Inc., is prescribed to treat patients with excessive sleepiness (ES) associated with narcolepsy, obstructive sleep apnea / hypopnea syndrome (OSAHS), and shift work sleep disorder. [read post]
13 Sep 2007, 6:08 pm
Drug manufacturer Cephalon Inc. is reporting that four people died after they improperly used FENTORA, a powerful painkiller. [read post]
13 Sep 2007, 6:08 pm
Drug manufacturer Cephalon Inc. is reporting that four people died after they improperly used FENTORA, a powerful painkiller. [read post]
27 Apr 2007, 12:04 pm
By Hal WegnerBefore an overflow hearing room on an internationally available web broadcast, Chairman Howard Berman of the House Judiciary Subcommittee relevant to patents hosted a most informative and candid hearing yesterday afternoon joined by roughly ten of his committee colleagues, including Rep. [read post]
2 Apr 2007, 7:08 pm
By Mark Chael --- On March 30, 2007, Cephalon, Inc. announced that it had received an approvable letter from the U.S. [read post]
23 Mar 2007, 11:35 am
., Beckman Coulter, Bridgestone Americas, Bristol-Myers Squibb, Cargill Incorporated, Caterpillar, Cephalon, CheckFree, Corning, Dow Chemical, Eastman Chemical, Electronics for Imaging, E.I. du Pont (DuPont), Eli Lilly, ExxonMobil, General Electric, Genzyme, GlaxoSmithKline, Henkel Corporation, Hoffman-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals, Monsanto, Motorola, Novartis, Patent Café.com Inc., Pfizer, Procter &… [read post]
10 Aug 2006, 2:59 pm
The Food and Drug Administration recently rejected approval of Cephalon Inc.'s newest drug Sparlon, an attention deficit/hyperactivity disorder drug, after it was found to trigger Stevens-Johnson Syndrome (SJS), a serve allergic reaction that often times is fatal. [read post]